(Duke University) A string of failed drug trials for Alzheimer's has researchers questioning the reigning approach to battling the disease, which focuses on preventing amyloid buildup in the brain. Duke scientists have identified a molecular mechanism that could help explain how neurons begin to falter even before amyloid clumps appear. The culprit, they say, may be 'jumping genes' that lose their normal controls with age and start to disrupt the machinery that fuels brain cells.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2m3mBM3
No comments:
Post a Comment